SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A health economic analysis of clinical islet transplantation
11 references·0 citing·43 second hop
A health economic analysis of clinical islet transplantation (2011)A health economic analysis of clinical is…A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment (2010)A Review of Methods Used in L…Economic Costs of Diabetes in the U.S. in 2007 (2008)Economic Costs of Diabetes in…Quality-of-Life Weights for the US Population (2007)Quality-of-Life Weights for t…The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making (2004)The CORE Diabetes Model: Proj…What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation? (2003)What Is the Price of Life and…Economic Costs of Diabetes in the U.S. in 2002 (2003)Economic Costs of Diabetes in…One Thousand Health-Related Quality-of-Life Estimates (2000)One Thousand Health-Related Q…Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial (1996)Lifetime Benefits and Costs o…Cost-Effectiveness in Health and Medicine (1996)Cost-Effectiveness in Health …Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL). (1995)Cost-effectiveness of ABMT in…Markov Models in Medical Decision Making (1993)Markov Models in Medical Deci…EuroQol - a new facility for the measurement of health-related quality of life (1990)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The MOS 36-ltem Short-Form Health Survey (SF-36) (1992)Cost-Effectiveness Analysis and the Consistency of Decision Making (2001)A review of health utilities using the EQ-5D in studies of cardiovascular disease (2010)Protected Values and Omission Bias (1999)Willingness to Pay for a Quality-adjusted Life Year (2000)What Does the Value of Modern Medicine Say About the $50,000 per Quality-Adjusted Life-Year Decision Rule? (2008)Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities (2009)A systematic review of the cost and cost-effectiveness studies of immune checkpoint inhibitors (2018)EuroQol: the current state of play (1996)Methods for the Economic Evaluation of Health Care Programmes (2005)A review of health utilities across conditions common in paediatric and adult populations (2010)Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 (2012)Impact of educational level on health-related quality of life (HRQL): results from Germany based on the EuroQol 5D (EQ-5D) (2012)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)Foundations of Cost-Effectiveness Analysis for Health and Medical Practices (1977)The Markov Process in Medical Prognosis (1983)An Introduction to Markov Modelling for Economic Evaluation (1998)Handling Uncertainty in Cost-Effectiveness Models (2000)Review of guidelines for good practice in decision-analytic modelling in health technology assessment (2004)Probabilistic Sensitivity Analysis Using Monte Carlo Simulation (1985)Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies (2003)Proceedings of the 2004 Winter Simulation Conference, 2004. (2004)Utilities and disutilities for attributes of injectable treatments for type 2 diabetes (2010)Review of Utility Values for Economic Modeling in Type 2 Diabetes (2014)Prevention effectiveness : a guide to decision analysis and economic evaluation (1996)Economic Consequences of Diabetes Mellitus in the U.S. in 1997 (1998)Ethnic Disparities in Diabetic Complications in an Insured Population (2002)Economic Costs of Diabetes in the U.S. in 2012 (2013)The State of US Health, 1990-2010 (2013)Social Determinants of Health and Diabetes: A Scientific Review (2020)Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure (2004)Global healthcare expenditure on diabetes for 2010 and 2030 (2010)Economic Costs of Diabetes in the U.S. in 2017 (2018)EQ-SD: a measure of health status from the EuroQol Group (2001)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography (2000)Cost-Effectiveness Analysis of Rituximab Combined with CHOP for Treatment of Diffuse Large B-Cell Lymphoma (2005)Systematic review of the use and value of computer simulation modelling in population health and health care delivery (2003)Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis (2004)Cost-effectiveness of Interventions to Manage Diabetes: Has the Evidence Changed Since 2008? (2020)
this work references cited by second hop

References

  • 1996Cost-Effectiveness in Health and Medicine7,192 cited
  • 2003Economic Costs of Diabetes in the U.S. in 20024,147 cited
  • 1993Markov Models in Medical Decision Making2,446 cited
  • 2008Economic Costs of Diabetes in the U.S. in 20071,360 cited
  • 2000One Thousand Health-Related Quality-of-Life Estimates662 cited
  • 2003What Is the Price of Life and Why Doesn't It Increase at the Rate of Inflation?588 cited
  • 2004The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making528 cited
  • 1996Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications Trial349 cited
  • 2007Quality-of-Life Weights for the US Population86 cited
  • 1995Cost-effectiveness of ABMT in comparison with CHOP chemotherapy in patients with intermediate- and high-grade malignant non-Hodgkin's lymphoma (NHL).57 cited
  • 2010A Review of Methods Used in Long-Term Cost-Effectiveness Models of Diabetes Mellitus Treatment56 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work